Endocrine Surgery Symposium

Thank you for participating in the MCW Endocrine Surgery Symposium. Please take a few minutes to complete this evaluation.

1 Start 2 Complete

Overall Symposium

Please rate the following:

	Strongly Agree	Agree	Neither Agree nor Disagree	Disagree	Strongly Disagree
Overall, the symposium met my expectations.	Overall, the symposium met my expectations. - Strongly Agree	Overall, the symposium met my expectations. - Agree	Overall, the symposium met my expectations. - Neither Agree nor Disagree	Overall, the symposium met my expectations. - Disagree	Overall, the symposium met my expectations. - Strongly Disagree
The content of the symposium met my expectations.	The content of the symposium met my expectations. - Strongly Agree	The content of the symposium met my expectations. - Agree	The content of the symposium met my expectations. - Neither Agree nor Disagree	The content of the symposium met my expectations. - Disagree	The content of the symposium met my expectations. - Strongly Disagree
The format was conducive to the meeting.	The format was conducive to the meeting. - Strongly Agree	The format was conducive to the meeting. - Agree	The format was conducive to the meeting. - Neither Agree nor Disagree	The format was conducive to the meeting. - Disagree	The format was conducive to the meeting. - Strongly Disagree
The location of the meeting was convenient.	The location of the meeting was convenient. - Strongly Agree	The location of the meeting was convenient. - Agree	The location of the meeting was convenient. - Neither Agree nor Disagree	The location of the meeting was convenient. - Disagree	The location of the meeting was convenient. - Strongly Disagree

Sessions

Please evaluate the content of each of the following sessions:

	Very Satisfied	Satisfied	Neutral	Dissatisfied	Very Dissatisfied	Did Not Attend
“Diagnosis and Management of 'Mild' Primary Hyperparathyroidism” Joseph L. Shaker, MD	“Diagnosis and Management of 'Mild' Primary Hyperparathyroidism” Joseph L. Shaker, MD - Very Satisfied	“Diagnosis and Management of 'Mild' Primary Hyperparathyroidism” Joseph L. Shaker, MD - Satisfied	“Diagnosis and Management of 'Mild' Primary Hyperparathyroidism” Joseph L. Shaker, MD - Neutral	“Diagnosis and Management of 'Mild' Primary Hyperparathyroidism” Joseph L. Shaker, MD - Dissatisfied	“Diagnosis and Management of 'Mild' Primary Hyperparathyroidism” Joseph L. Shaker, MD - Very Dissatisfied	“Diagnosis and Management of 'Mild' Primary Hyperparathyroidism” Joseph L. Shaker, MD - Did Not Attend
“Genetic Evaluation for Primary Hyperparathyroidism” Amy E. Donahue, MLIS, MGCS, CGC	“Genetic Evaluation for Primary Hyperparathyroidism” Amy E. Donahue, MLIS, MGCS, CGC - Very Satisfied	“Genetic Evaluation for Primary Hyperparathyroidism” Amy E. Donahue, MLIS, MGCS, CGC - Satisfied	“Genetic Evaluation for Primary Hyperparathyroidism” Amy E. Donahue, MLIS, MGCS, CGC - Neutral	“Genetic Evaluation for Primary Hyperparathyroidism” Amy E. Donahue, MLIS, MGCS, CGC - Dissatisfied	“Genetic Evaluation for Primary Hyperparathyroidism” Amy E. Donahue, MLIS, MGCS, CGC - Very Dissatisfied	“Genetic Evaluation for Primary Hyperparathyroidism” Amy E. Donahue, MLIS, MGCS, CGC - Did Not Attend
“Outcomes after parathyroidectomy for pHPT” Tina Yen, MD	“Outcomes after parathyroidectomy for pHPT” Tina Yen, MD - Very Satisfied	“Outcomes after parathyroidectomy for pHPT” Tina Yen, MD - Satisfied	“Outcomes after parathyroidectomy for pHPT” Tina Yen, MD - Neutral	“Outcomes after parathyroidectomy for pHPT” Tina Yen, MD - Dissatisfied	“Outcomes after parathyroidectomy for pHPT” Tina Yen, MD - Very Dissatisfied	“Outcomes after parathyroidectomy for pHPT” Tina Yen, MD - Did Not Attend
“Surgical approaches for pHPT” Patrick Hangge, MD	“Surgical approaches for pHPT” Patrick Hangge, MD - Very Satisfied	“Surgical approaches for pHPT” Patrick Hangge, MD - Satisfied	“Surgical approaches for pHPT” Patrick Hangge, MD - Neutral	“Surgical approaches for pHPT” Patrick Hangge, MD - Dissatisfied	“Surgical approaches for pHPT” Patrick Hangge, MD - Very Dissatisfied	“Surgical approaches for pHPT” Patrick Hangge, MD - Did Not Attend
“Initial Evaluation of Thyroid Nodules & Molecular Testing” Gilbert Fareau, MD	“Initial Evaluation of Thyroid Nodules & Molecular Testing” Gilbert Fareau, MD - Very Satisfied	“Initial Evaluation of Thyroid Nodules & Molecular Testing” Gilbert Fareau, MD - Satisfied	“Initial Evaluation of Thyroid Nodules & Molecular Testing” Gilbert Fareau, MD - Neutral	“Initial Evaluation of Thyroid Nodules & Molecular Testing” Gilbert Fareau, MD - Dissatisfied	“Initial Evaluation of Thyroid Nodules & Molecular Testing” Gilbert Fareau, MD - Very Dissatisfied	“Initial Evaluation of Thyroid Nodules & Molecular Testing” Gilbert Fareau, MD - Did Not Attend
“Thyroid Disease in the Pediatric Population” Samuel Engle, MD	“Thyroid Disease in the Pediatric Population” Samuel Engle, MD - Very Satisfied	“Thyroid Disease in the Pediatric Population” Samuel Engle, MD - Satisfied	“Thyroid Disease in the Pediatric Population” Samuel Engle, MD - Neutral	“Thyroid Disease in the Pediatric Population” Samuel Engle, MD - Dissatisfied	“Thyroid Disease in the Pediatric Population” Samuel Engle, MD - Very Dissatisfied	“Thyroid Disease in the Pediatric Population” Samuel Engle, MD - Did Not Attend
“Update on WHO Terminology (Pathology)” Tamara Giorgadze, MD	“Update on WHO Terminology (Pathology)” Tamara Giorgadze, MD - Very Satisfied	“Update on WHO Terminology (Pathology)” Tamara Giorgadze, MD - Satisfied	“Update on WHO Terminology (Pathology)” Tamara Giorgadze, MD - Neutral	“Update on WHO Terminology (Pathology)” Tamara Giorgadze, MD - Dissatisfied	“Update on WHO Terminology (Pathology)” Tamara Giorgadze, MD - Very Dissatisfied	“Update on WHO Terminology (Pathology)” Tamara Giorgadze, MD - Did Not Attend
“Management of Benign Thyroid Tumors, Including Surgery and Radiofrequency Ablation” Sophie Dream, MD	“Management of Benign Thyroid Tumors, Including Surgery and Radiofrequency Ablation” Sophie Dream, MD - Very Satisfied	“Management of Benign Thyroid Tumors, Including Surgery and Radiofrequency Ablation” Sophie Dream, MD - Satisfied	“Management of Benign Thyroid Tumors, Including Surgery and Radiofrequency Ablation” Sophie Dream, MD - Neutral	“Management of Benign Thyroid Tumors, Including Surgery and Radiofrequency Ablation” Sophie Dream, MD - Dissatisfied	“Management of Benign Thyroid Tumors, Including Surgery and Radiofrequency Ablation” Sophie Dream, MD - Very Dissatisfied	“Management of Benign Thyroid Tumors, Including Surgery and Radiofrequency Ablation” Sophie Dream, MD - Did Not Attend
“Management of low-risk DTC” Linwah Yip, MD	“Management of low-risk DTC” Linwah Yip, MD - Very Satisfied	“Management of low-risk DTC” Linwah Yip, MD - Satisfied	“Management of low-risk DTC” Linwah Yip, MD - Neutral	“Management of low-risk DTC” Linwah Yip, MD - Dissatisfied	“Management of low-risk DTC” Linwah Yip, MD - Very Dissatisfied	“Management of low-risk DTC” Linwah Yip, MD - Did Not Attend
“Management of locoregional advanced cancers” Douglas B. Evans, MD	“Management of locoregional advanced cancers” Douglas B. Evans, MD - Very Satisfied	“Management of locoregional advanced cancers” Douglas B. Evans, MD - Satisfied	“Management of locoregional advanced cancers” Douglas B. Evans, MD - Neutral	“Management of locoregional advanced cancers” Douglas B. Evans, MD - Dissatisfied	“Management of locoregional advanced cancers” Douglas B. Evans, MD - Very Dissatisfied	“Management of locoregional advanced cancers” Douglas B. Evans, MD - Did Not Attend
“Use of Autofluorescence in Thyroid and Parathyroid Surgery” Carmen Solorzano, MD, PhD	“Use of Autofluorescence in Thyroid and Parathyroid Surgery” Carmen Solorzano, MD, PhD - Very Satisfied	“Use of Autofluorescence in Thyroid and Parathyroid Surgery” Carmen Solorzano, MD, PhD - Satisfied	“Use of Autofluorescence in Thyroid and Parathyroid Surgery” Carmen Solorzano, MD, PhD - Neutral	“Use of Autofluorescence in Thyroid and Parathyroid Surgery” Carmen Solorzano, MD, PhD - Dissatisfied	“Use of Autofluorescence in Thyroid and Parathyroid Surgery” Carmen Solorzano, MD, PhD - Very Dissatisfied	“Use of Autofluorescence in Thyroid and Parathyroid Surgery” Carmen Solorzano, MD, PhD - Did Not Attend
“Management of the Voice During Cervical Surgery” Joel Blumin, MD	“Management of the Voice During Cervical Surgery” Joel Blumin, MD - Very Satisfied	“Management of the Voice During Cervical Surgery” Joel Blumin, MD - Satisfied	“Management of the Voice During Cervical Surgery” Joel Blumin, MD - Neutral	“Management of the Voice During Cervical Surgery” Joel Blumin, MD - Dissatisfied	“Management of the Voice During Cervical Surgery” Joel Blumin, MD - Very Dissatisfied	“Management of the Voice During Cervical Surgery” Joel Blumin, MD - Did Not Attend
“Precision Approach to Differentiated Thyroid Cancer” Aditya Shreenivas, MD, MS	“Precision Approach to Differentiated Thyroid Cancer” Aditya Shreenivas, MD, MS - Very Satisfied	“Precision Approach to Differentiated Thyroid Cancer” Aditya Shreenivas, MD, MS - Satisfied	“Precision Approach to Differentiated Thyroid Cancer” Aditya Shreenivas, MD, MS - Neutral	“Precision Approach to Differentiated Thyroid Cancer” Aditya Shreenivas, MD, MS - Dissatisfied	“Precision Approach to Differentiated Thyroid Cancer” Aditya Shreenivas, MD, MS - Very Dissatisfied	“Precision Approach to Differentiated Thyroid Cancer” Aditya Shreenivas, MD, MS - Did Not Attend
“Evaluation of Adrenal Nodules” Ty Carroll, MD	“Evaluation of Adrenal Nodules” Ty Carroll, MD - Very Satisfied	“Evaluation of Adrenal Nodules” Ty Carroll, MD - Satisfied	“Evaluation of Adrenal Nodules” Ty Carroll, MD - Neutral	“Evaluation of Adrenal Nodules” Ty Carroll, MD - Dissatisfied	“Evaluation of Adrenal Nodules” Ty Carroll, MD - Very Dissatisfied	“Evaluation of Adrenal Nodules” Ty Carroll, MD - Did Not Attend
“Evaluation of the HPA-Axis” James W. Findling, MD	“Evaluation of the HPA-Axis” James W. Findling, MD - Very Satisfied	“Evaluation of the HPA-Axis” James W. Findling, MD - Satisfied	“Evaluation of the HPA-Axis” James W. Findling, MD - Neutral	“Evaluation of the HPA-Axis” James W. Findling, MD - Dissatisfied	“Evaluation of the HPA-Axis” James W. Findling, MD - Very Dissatisfied	“Evaluation of the HPA-Axis” James W. Findling, MD - Did Not Attend
“Long-Term Outcomes of Mild Adrenal Cortisol Excess” Catherine Zhang, MD	“Long-Term Outcomes of Mild Adrenal Cortisol Excess” Catherine Zhang, MD - Very Satisfied	“Long-Term Outcomes of Mild Adrenal Cortisol Excess” Catherine Zhang, MD - Satisfied	“Long-Term Outcomes of Mild Adrenal Cortisol Excess” Catherine Zhang, MD - Neutral	“Long-Term Outcomes of Mild Adrenal Cortisol Excess” Catherine Zhang, MD - Dissatisfied	“Long-Term Outcomes of Mild Adrenal Cortisol Excess” Catherine Zhang, MD - Very Dissatisfied	“Long-Term Outcomes of Mild Adrenal Cortisol Excess” Catherine Zhang, MD - Did Not Attend
“Management of ACTH - Independent Hypercortisolism (Primary and Recurrence)” Adriana Ioachimescu, MD, PhD	“Management of ACTH - Independent Hypercortisolism (Primary and Recurrence)” Adriana Ioachimescu, MD, PhD - Very Satisfied	“Management of ACTH - Independent Hypercortisolism (Primary and Recurrence)” Adriana Ioachimescu, MD, PhD - Satisfied	“Management of ACTH - Independent Hypercortisolism (Primary and Recurrence)” Adriana Ioachimescu, MD, PhD - Neutral	“Management of ACTH - Independent Hypercortisolism (Primary and Recurrence)” Adriana Ioachimescu, MD, PhD - Dissatisfied	“Management of ACTH - Independent Hypercortisolism (Primary and Recurrence)” Adriana Ioachimescu, MD, PhD - Very Dissatisfied	“Management of ACTH - Independent Hypercortisolism (Primary and Recurrence)” Adriana Ioachimescu, MD, PhD - Did Not Attend
“Inferior Petrosal Sinus Sampling” Marc A. Lazzaro, MD	“Inferior Petrosal Sinus Sampling” Marc A. Lazzaro, MD - Very Satisfied	“Inferior Petrosal Sinus Sampling” Marc A. Lazzaro, MD - Satisfied	“Inferior Petrosal Sinus Sampling” Marc A. Lazzaro, MD - Neutral	“Inferior Petrosal Sinus Sampling” Marc A. Lazzaro, MD - Dissatisfied	“Inferior Petrosal Sinus Sampling” Marc A. Lazzaro, MD - Very Dissatisfied	“Inferior Petrosal Sinus Sampling” Marc A. Lazzaro, MD - Did Not Attend
“Pituitary Surgery” Nathan Zwagerman, MD	“Pituitary Surgery” Nathan Zwagerman, MD - Very Satisfied	“Pituitary Surgery” Nathan Zwagerman, MD - Satisfied	“Pituitary Surgery” Nathan Zwagerman, MD - Neutral	“Pituitary Surgery” Nathan Zwagerman, MD - Dissatisfied	“Pituitary Surgery” Nathan Zwagerman, MD - Very Dissatisfied	“Pituitary Surgery” Nathan Zwagerman, MD - Did Not Attend
“Surgical Approaches to Adrenalectomy” Tracy S. Wang, MD, MPH	“Surgical Approaches to Adrenalectomy” Tracy S. Wang, MD, MPH - Very Satisfied	“Surgical Approaches to Adrenalectomy” Tracy S. Wang, MD, MPH - Satisfied	“Surgical Approaches to Adrenalectomy” Tracy S. Wang, MD, MPH - Neutral	“Surgical Approaches to Adrenalectomy” Tracy S. Wang, MD, MPH - Dissatisfied	“Surgical Approaches to Adrenalectomy” Tracy S. Wang, MD, MPH - Very Dissatisfied	“Surgical Approaches to Adrenalectomy” Tracy S. Wang, MD, MPH - Did Not Attend

Panel Case Discussions

With respect to the following: The sessions met my expectations:

	Strongly Agree	Agree	Neither Agree nor Disagree	Disagree	Strongly Disagree	Did Not Attend
Session I: Parathyroid Panel Case Discussions	Session I: Parathyroid Panel Case Discussions - Strongly Agree	Session I: Parathyroid Panel Case Discussions - Agree	Session I: Parathyroid Panel Case Discussions - Neither Agree nor Disagree	Session I: Parathyroid Panel Case Discussions - Disagree	Session I: Parathyroid Panel Case Discussions - Strongly Disagree	Session I: Parathyroid Panel Case Discussions - Did Not Attend
Session II: Thyroid Panel Case Discussions	Session II: Thyroid Panel Case Discussions - Strongly Agree	Session II: Thyroid Panel Case Discussions - Agree	Session II: Thyroid Panel Case Discussions - Neither Agree nor Disagree	Session II: Thyroid Panel Case Discussions - Disagree	Session II: Thyroid Panel Case Discussions - Strongly Disagree	Session II: Thyroid Panel Case Discussions - Did Not Attend
Session III: Adrenal and Pituitary Neuroendocrine Tumor Panel Case Discussions	Session III: Adrenal and Pituitary Neuroendocrine Tumor Panel Case Discussions - Strongly Agree	Session III: Adrenal and Pituitary Neuroendocrine Tumor Panel Case Discussions - Agree	Session III: Adrenal and Pituitary Neuroendocrine Tumor Panel Case Discussions - Neither Agree nor Disagree	Session III: Adrenal and Pituitary Neuroendocrine Tumor Panel Case Discussions - Disagree	Session III: Adrenal and Pituitary Neuroendocrine Tumor Panel Case Discussions - Strongly Disagree	Session III: Adrenal and Pituitary Neuroendocrine Tumor Panel Case Discussions - Did Not Attend

Clinical Practice

Did you (will you) use this information for a specific patient?

Possibly

Yes

Commercial Bias *

This symposium was free of commercial bias.

Yes

Purpose of attending

I attended this symposium for the opportunity to (Check all that apply):

Network with other medical professionals

Continue my own professional development

Present my scientific/academic work

Other...

Purpose of attending Other...

Future Symposium

I would attend another MCW Endocrine Surgery symposium.

Yes

Maybe

Comments

Any additional comments or suggestions?

Leave this field blank

You are here